iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Trading Down 1.3% – Should You Sell?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) shares fell 1.3% on Tuesday . The company traded as low as $21.48 and last traded at $21.78. 17,987 shares changed hands during mid-day trading, a decline of 41% from the average session volume of 30,319 shares. The stock had previously closed at $22.06.

iShares Genomics Immunology and Healthcare ETF Stock Down 1.3 %

The firm has a market capitalization of $112.17 million, a PE ratio of 23.93 and a beta of 1.03. The business’s 50-day moving average price is $22.57 and its 200-day moving average price is $23.61.

Hedge Funds Weigh In On iShares Genomics Immunology and Healthcare ETF

An institutional investor recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC purchased a new stake in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 9,500 shares of the company’s stock, valued at approximately $234,000. Avior Wealth Management LLC owned about 0.16% of iShares Genomics Immunology and Healthcare ETF at the end of the most recent reporting period.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.